Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vaccine

Pharma Firm SIGA Cashes In On Monkeypox Scare

New York-based pharmaceutical firm SIGA Technologies (NASDAQ: SIGA) is among the companies to benefit from the growing threat of monkeypox, recently pushing its shares to an almost decade-high after the company obtained approval in Europe to use its TPOXX antiviral drug for the treatment of monkeypox.

Benzinga

Long COVID: vaccination could reduce symptoms, new research suggests

Graham was a healthy 34-year-old until he developed COVID in July 2020. Along with his wife and children, he had a fever, a cough, breathlessness, profound fatigue and he lost his sense of smell.

The Conversation

Scientist behind covid vaccine explains what UK must do to control monkeypox outbreak

Dame Sarah Gilbert and Dr Catherine Green helped create the Oxford, AstraZeneca vaccine

Liverpool Echo

From analysis to the latest developments in health,
read the most diverse news in one place.

The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Why won't more seniors get boosters?

Poor messaging around booster shots has left millions at risk, researchers say

Salon

Explainer: What vaccines, treatments do we have to combat monkeypox?

With cases of monkeypox inexplicably on the rise outside of Africa - where the viral disease is endemic - public health officials are using contact tracing, isolation and targeted vaccination to curb its spread.

Bangkok Post

Holidaymakers' vaccine helpline launched to avoid Covid travel misery

Some countries do not allow entry without proof of full vaccination, while others operate strict testing regimes

Wales Online

Read news from The Economist, FT, and more,
with one subscription

Pfizer To Sell 23 Patented Drugs, Vaccines At Lower Prices To Poorer Countries

Pfizer Inc (NYSE:PFE) will sell over 20 patent-protected drugs and vaccines at not-for-profit prices to 45 of the world's poorest countries. Under the program, Pfizer will begin shipping the medicines first to Ghana, Malawi, Rwanda, Senegal, and Uganda before the end of this year, Chief Executive Albert Bourla said in an interview. This will…

Benzinga

Push for targeted monkeypox vaccine rollout in France, Denmark

Health authorities in France and Denmark want to start a vaccination campaign targeting adults who have been exposed to monkeypox – a milder version of smallpox that spreads easily through sexual activity.

Radio France Internationale

Monkeypox is endemic in Nigeria. But surveillance isn't what it should be

There has been an outbreak of monkeypox cases in a number of countries that are not endemic for the virus. Monkeypox is caused by an orthopoxvirus that is closely related to the virus that caused smallpox. Monkeypox is an animal virus that occasionally infects humans after they are bitten or…

The Conversation

Davos updates | Pfizer offers low-cost drugs to poor nations

Pfizer says it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world’s poorest countries

The Independent UK

Monkeypox: What employers and staff need to know as cases rise

The first confirmed case of the virus was identified in Scotland on Monday

Insider UK

Cambodia, Laos to benefit as Pfizer slashes drug prices for poorest nations

Pfizer Inc plans to sell its entire portfolio of brand-name drugs at cost in as many as 45 lower-income countries, including Cambodia and Laos, one of the most comprehensive and ambitious drug-access programmes ever announced by a large pharmaceutical manufacturer.

Bangkok Post

Most States Now Offer Free Flu Shots So Here’s How Get One And Avoid A Drippy Nussy

Simply fab news for hot girl winter.

Pedestrian.tv

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

The Loop: Calls for gun control after US mass shooting, and more Aussies eligible for fourth COVID-19 vaccine dose

Get up to speed on today's headlines with The Loop.

The Independent UK

Pfizer to offer low-cost medicines, vaccines to poor nations

Pfizer says it will provide nearly two dozen products at not-for-profit prices in some of the world’s poorest countries

ABC News

Shire of York agrees to ratepayer's request asking WA Premier Mark McGowan to end vaccine mandates

The Shire of York will write to WA Premier Mark McGowan on behalf of its ratepayers, who are demanding an end to Covid-19 vaccine mandates.

The Guardian - AU

High-risk people eligible for second Covid booster vaccine under new Australian guidelines

From Monday about 1.5 million aged 16-64 qualify for fourth dose after updated advice that excludes people without serious risk factors

Get all your
news in one place.

100’s of premium titles.
One news app.

AAP

Second COVID booster eligibility expanded

An extra 1.5 million people are now eligible to receive a fourth COVID-19 vaccine, or second booster.

ABC News

ATAGI expands COVID-19 booster access to allow more people to get a fourth dose

The nation's vaccine advisory group recommends another 1.5 million Australians get a fourth COVID-19 booster shot coming into the winter months.

ABC News

Spike in influenza cases in the Northern Territory, as Chief Minister considers whether more people should be offered free vaccines

So far this year, the Northern Territory has recorded 968 cases of influenza, compared to just 76 cases in all of 2021.

Benzinga

SVB Sees De-Risked Opportunity For This Newly Listed Norovirus Vaccine

SVB Leerink is initiating coverage of HilleVax Inc (NASDAQ:HLVX) shares with an Outperform rating and a $30 price target. The analyst believes the company’s potentially first-in-class infant norovirus vaccine HIL214 represents a uniquely de-risked opportunity. It estimates $625 million in risk-adjusted infant HIL214 sales in 2030E ($1 billion unadjusted). The outlook is supported by…

Benzinga

This Famed Company Is Working On A Potential Monkeypox Vaccine

As cases of monkeypox continue to rise, Moderna Inc (NASDAQ: MRNA) is probably working on its platform towards finding a vaccine shot against the disease.

Chicago Sun-Times

Monkeypox explained: What this rare disease is, where it’s spreading, why it’s called that

A doctor heading a World Health Organization group says the outbreak in developed countries is ‘a random event’ possibly explained by risky sexual behavior at two raves in Europe.

Manchester Evening News

'Concerned' medics have a plan to deal with Monkeypox if it spreads to Greater Manchester

Hospitals in Greater Manchester are understood to be preparing for monkeypox

1 … 238 239 240 241

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

UK Health Security Agency

Public Health Scotland

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.